129 related articles for article (PubMed ID: 6562156)
1. Immunoreactive tissue kallikrein in human serum.
Shimamoto K; Mayfield RK; Margolius HS; Chao J; Stroud W; Kaplan AP
J Lab Clin Med; 1984 May; 103(5):731-8. PubMed ID: 6562156
[TBL] [Abstract][Full Text] [Related]
2. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
Saito H; Ratnoff OD
J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical studies of plasma kallikrein.
Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
[TBL] [Abstract][Full Text] [Related]
4. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).
Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA
Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094
[TBL] [Abstract][Full Text] [Related]
5. The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements.
Shimamoto K; Chao J; Margolius HS
J Clin Endocrinol Metab; 1980 Oct; 51(4):840-8. PubMed ID: 6903188
[TBL] [Abstract][Full Text] [Related]
6. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
7. [The mechanism of activation of kallikrein-kinin system in the plasma of patients with atopic allergic diseases].
Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Iarovaia GA
Vopr Med Khim; 1988; 34(6):89-94. PubMed ID: 3238945
[TBL] [Abstract][Full Text] [Related]
8. Effects of restriction of sodium or administration of fludrocortisone on parotid salivary kallikrein in man.
Horwitz D; Proud D; Lawton WJ; Yates KN; Highet P; Pisano JJ; Keiser HR
J Lab Clin Med; 1982 Jul; 100(1):146-54. PubMed ID: 6919568
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material.
Saito H; Goodnough LT; Soria J; Soria C; Aznar J; España F
N Engl J Med; 1981 Oct; 305(16):910-4. PubMed ID: 6792540
[TBL] [Abstract][Full Text] [Related]
10. Gender differences of human tissue kallikrein and an erythrocyte kallikrein-like enzyme in essential hypertension.
Hughes GS; Margolius HS; Peters R; Oexmann MJ; Chao J; Lindenmayer G
J Lab Clin Med; 1988 Nov; 112(5):612-8. PubMed ID: 3183493
[TBL] [Abstract][Full Text] [Related]
11. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
[TBL] [Abstract][Full Text] [Related]
12. Contact activation of human plasma prorenin in vitro.
Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
[TBL] [Abstract][Full Text] [Related]
13. A direct radioimmunoassay of rat urinary kallikrein and comparison with other measures of urinary kallikrein activity.
Shimamoto K; Margolius HS; Chao J; Crosswell AR
J Lab Clin Med; 1979 Jul; 94(1):172-9. PubMed ID: 469374
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a microassay for human plasma prekallikrein.
De La Cadena RA; Scott CF; Colman RW
J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the rat urinary plasminogen activator (esterase A) by direct radioimmunoassay in urine and tissue.
Chao J; Shimamoto K; Margolius HS
Hoppe Seylers Z Physiol Chem; 1984 Sep; 365(9):1137-44. PubMed ID: 6568199
[TBL] [Abstract][Full Text] [Related]
16. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
Alving BM; Tankersley DL; Mason BL
J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
[TBL] [Abstract][Full Text] [Related]
17. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
Bork K; Kleist R; Hardt J; Witzke G
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
[TBL] [Abstract][Full Text] [Related]
19. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome.
Hernández CC; Donadi EA; Reis ML
J Rheumatol; 1998 Dec; 25(12):2381-4. PubMed ID: 9858433
[TBL] [Abstract][Full Text] [Related]
20. [Kallikrein and prekallikrein content and antitryptic activity in the blood serum in serum hepatitis of varying degrees of severity].
Iakubovskaia RI; Malyshev NA; Farber NA; Didkovskiĭ NA; Paskhina TS
Vopr Med Khim; 1981; 27(6):804-11. PubMed ID: 6977940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
